Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07701967 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Efficacy and Safety of Depemokimab Monotherapy Without Concomitant Use of Intranasal Corticosteroids (INCS) in Japanese Participants With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)

Name: Efficacy and Safety of Depemokimab Monotherapy Without Concomitant Use of Intranasal Corticosteroids (INCS) in Japanese Participants With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) — clinical trial record (NCT07701967)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusNot Yet Recruiting

PhasePhase 4

SponsorGlaxoSmithKline

Started2026-07-20

View on ClinicalTrials.gov ↗

This study will evaluate the efficacy and safety of depemokimab (GSK3511294) without concomitant use of Intranasal corticosteroids (INCS) in participants with Chronic rhinosinusitis with nasal polyps (CRSwNP).

Trial Details

NCT Number	NCT07701967
Lead Sponsor	GlaxoSmithKline
Conditions	Nasal Polyps
Enrollment	28 participants
Start Date	2026-07-20
Primary Completion	2027-07-01 (estimated)
Study Completion	2028-06-16 (estimated)
Updated on ClinicalTrials.gov	2026-07-14